NY-ESO-1 overlapping peptides
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NY-ESO-1 overlapping peptides, covering 2018-07-27 to 2018-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]